search
Back to results

An Investigation to Test a Prototype Full-face Mask in the Home Setting

Primary Purpose

Sleep Disordered Breathing, Obstructive Sleep Apnea

Status
Completed
Phase
Not Applicable
Locations
New Zealand
Study Type
Interventional
Intervention
Jupiter Full Face Mask
Sponsored by
Fisher and Paykel Healthcare
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sleep Disordered Breathing

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria

  • 18+ years of age
  • Diagnosed with OSA by a practicing physician
  • Prescribed PAP therapy (Bi-Level or Continuous Positive Airway Pressure (CPAP) or Automatic Positive Airway Pressure (APAP)). Patient can be naïve to CPAP therapy or experienced (6 months and more)
  • Existing full face mask users
  • Patients who are able to put on and remove their current mask without gross difficulty relating to an existing condition (e.g. arthritis of the hands).

Exclusion Criteria

  • Inability to give informed consent
  • Anatomical or physiological conditions making PAP therapy inappropriate (e.g unconsolidated facial fracture)
  • Commercial Drivers who are investigated by New Zealand Transport Agency (NZTA)
  • Current diagnosis of CO2 retention
  • Pregnant or think they may be pregnant

Sites / Locations

  • Fisher & Paykel Healthcare
  • Wellsleep: Bowen Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Jupiter Full Face Mask

Arm Description

Participants to use full face mask in-home for a 14 ± 3 days in-home.

Outcomes

Primary Outcome Measures

Objective mask leak data measurement (System Leak)
Obtained from participant's CPAP device, measured in L/min
Subjective Measurement of leak assessed using a Subjective Questionnaire
Subjective Questionnaire
Comfort assessed using a Subjective Questionnaire
Subjective Questionnaire
Stability assessed using a Subjective Questionnaire
Subjective Questionnaire
Draft assessed using a Subjective Questionnaire
Subjective Questionnaire
Noise assessed using a Subjective Questionnaire
Subjective Questionnaire

Secondary Outcome Measures

Preference of Mask assessed using a Subjective Questionnaire
Subjective Questionnaire
Usability via mask unboxing/fitting exercise with a subjective questionnaire
Usability activity during visit 2 with subjective questionnaire after activity

Full Information

First Posted
October 16, 2016
Last Updated
July 24, 2017
Sponsor
Fisher and Paykel Healthcare
search

1. Study Identification

Unique Protocol Identification Number
NCT02938208
Brief Title
An Investigation to Test a Prototype Full-face Mask in the Home Setting
Official Title
An Investigation to Test a Prototype Full-face Mask in the Home Setting
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Completed
Study Start Date
November 3, 2016 (Actual)
Primary Completion Date
November 21, 2016 (Actual)
Study Completion Date
May 31, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fisher and Paykel Healthcare

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This investigation is a prospective non-blinded and non-randomized clinical investigation. This investigation is designed to evaluate the performance (leak and comfort) as well as participant's overall acceptance of the Jupiter mask amongst OSA participants. A total number of up to 15 OSA participants who currently use full face masks will be recruited for the trial.
Detailed Description
This investigation is designed to evaluate the performance (leak and comfort) as well as participant's overall acceptance of the Jupiter mask amongst OSA participants. A total number of up to 15 OSA participants who currently use full face masks will be recruited for the trial. The participants will be recruited from the Fisher and Paykel Healthcare Database of subjects with OSA (Ethics reference NTY/08/06/064), Auckland District Health Board (ADHB), or WellSleep Centre (Bowen Hospital, Wellington, NZ). Participants will be on the trial for 21 days ± 6 days, using the prototypes at home for 14 days ± 3 days. PAP baseline data on the participant's prescribed treatment pressure with their usual mask and will be collected for 7 days ± 3 days prior to mask fitting with the Jupiter trial mask. Fisher and Paykel Healthcare will act as the investigator and sponsor for this investigation. This study will be conducted in accordance with ICH/GCP Guidelines. No deviation from the protocol will be implemented without prior review and approval of the sponsor except where it may be necessary to eliminate an immediate hazard to a research participant. In such case, the deviation will be reported to the sponsor (Bhavi Ogra) as soon as possible.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disordered Breathing, Obstructive Sleep Apnea

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
14 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Jupiter Full Face Mask
Arm Type
Experimental
Arm Description
Participants to use full face mask in-home for a 14 ± 3 days in-home.
Intervention Type
Device
Intervention Name(s)
Jupiter Full Face Mask
Intervention Description
Full Face Mask for the treatment of obstructive sleep apnea (OSA) using CPAP therapy.
Primary Outcome Measure Information:
Title
Objective mask leak data measurement (System Leak)
Description
Obtained from participant's CPAP device, measured in L/min
Time Frame
Up to 21 ± 6 days in-home
Title
Subjective Measurement of leak assessed using a Subjective Questionnaire
Description
Subjective Questionnaire
Time Frame
Up to 21 ± 6 days in-home
Title
Comfort assessed using a Subjective Questionnaire
Description
Subjective Questionnaire
Time Frame
Up to 21 ± 6 days in-home
Title
Stability assessed using a Subjective Questionnaire
Description
Subjective Questionnaire
Time Frame
Up to 21 ± 6 days in-home
Title
Draft assessed using a Subjective Questionnaire
Description
Subjective Questionnaire
Time Frame
Up to 21 ± 6 days in-home
Title
Noise assessed using a Subjective Questionnaire
Description
Subjective Questionnaire
Time Frame
Up to 21 ± 6 days in-home
Secondary Outcome Measure Information:
Title
Preference of Mask assessed using a Subjective Questionnaire
Description
Subjective Questionnaire
Time Frame
Up to 21 ± 6 days in-home
Title
Usability via mask unboxing/fitting exercise with a subjective questionnaire
Description
Usability activity during visit 2 with subjective questionnaire after activity
Time Frame
Up to 21 ± 6 days in-home

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria 18+ years of age Diagnosed with OSA by a practicing physician Prescribed PAP therapy (Bi-Level or Continuous Positive Airway Pressure (CPAP) or Automatic Positive Airway Pressure (APAP)). Patient can be naïve to CPAP therapy or experienced (6 months and more) Existing full face mask users Patients who are able to put on and remove their current mask without gross difficulty relating to an existing condition (e.g. arthritis of the hands). Exclusion Criteria Inability to give informed consent Anatomical or physiological conditions making PAP therapy inappropriate (e.g unconsolidated facial fracture) Commercial Drivers who are investigated by New Zealand Transport Agency (NZTA) Current diagnosis of CO2 retention Pregnant or think they may be pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kayan Gonda, BSc
Organizational Affiliation
Sponsor Employee
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fisher & Paykel Healthcare
City
Auckland
ZIP/Postal Code
2013
Country
New Zealand
Facility Name
Wellsleep: Bowen Hospital
City
Wellington
ZIP/Postal Code
6035
Country
New Zealand

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
This is an investigation for a prototype full face mask. The results from this trial will feedback into product development on further improving the full face mask for future trials and impending release of the product.

Learn more about this trial

An Investigation to Test a Prototype Full-face Mask in the Home Setting

We'll reach out to this number within 24 hrs